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Background: Pre-hospital paramedic (EMT-P) cardiac catheterization laboratory (cath lab) activation is becoming an accepted treatment option 
for patients with ST Elevation Myocardial Infarction (STEMI). We compared in-hospital mortality for STEMI patients who were EMT-P identified with 
pre-hospital cath lab activation, with those of referring hospital ED activations, cath lab hospital ED activations, and the ACTION Registry.
Methods: We retrospectively analyzed records of consecutive patients taken to the cath lab hospital in our system with a diagnosis of STEMI from 
June 2003 through March 2009. Pre-hospital STEMI was diagnosed on the basis of heart equivalent discomfort < 12 hours, age less than 86 years, 
absence of left bundle branch block, and ST elevation in at least 2 contiguous leads (1 mm ST elevation in leads II, III, aVF, I, aVL, V4 - V6, or 2 mm 
in V1 - V3) as identified by the PhysioControl LifePack 12 autoanalyzer or by EMT-P interpretation.
Results: The in-hospital mortality rate for the 273 patients identified as having a STEMI in the field with cath lab activation by EMT-Ps was 2.9%, 
compared with 4.3% for the 352 patients transferred from the referring hospital ED, and 3.3% for the 150 patients identified at the cath lab hospital 
ED. In-hospital mortality was similar for all 3 groups (p = 0.66). All 3 groups were of similar age (p = 0.42) and gender (p = 0.76). A 2008 analysis 
of the ACTION Registry reported 5.7% in-hospital mortality for 20,681 STEMI patients which was statistically similar, although trended much higher, 
compared to our EMT-P identified patients (p = 0.07).
Conclusions: In-hospital mortality in our system of STEMI care, was statistically similar among all groups, with a trend favoring pre-hospital EMT-P 
STEMI identification and cath lab activation compared to referring hospital ED activations, cath lab hospital ED activations, and the ACTION Registry.
Limitations of this study include the small number of patients, our single system applicability, lack of patient demographic detail, and the short-term 
outcome of in-hospital mortality.
In our experience, patient care as measured by mortality improved with pre-hospital EMT-P STEMI identification and cath lab activation.
